References
- Claesson MH, Rudolphi A, Kofoed S, et al. CD4+ T lymphocytes injected into severe combined immunodeficient (SCID) mice lead to an inflammatory and lethal bowel disease. Clin Exp Immunol 1996;104:491–500. http://dx.doi.org/10.1046/j.1365-2249.1996.48757.x
- Claesson MH, Bregenholt S, Bonhagen K, et al. Colitis-inducing potency of CD4+ T cells in immunodeficient, adoptive hosts depends on their state of activation, IL-12 responsiveness, and CD45RB surface phenotype. J Immunol 1999;162:3702–10. PubMed PMID: 10092833
- Read S, Powrie F. Induction of inflammatory bowel disease in immunodeficient mice by depletion of regulatory T cells. Curr Protoc Immunol 2001 May; Chapter 15: Unit 15.13. PubMed PMID: 18432730
- Bilsborough J, Viney JL. Getting to the guts of immune regulation. Immunology 2002;106:139–143. PubMed ID: 12047743; PubMed Central ID: PMC1782714
- Mowat AM. Anatomical basis of tolerance and immunity to intestinal antigens. Nat Rev Immunol 2003;3:331–341 [Review]. PubMed ID: 12669023
- Prasad DVR, Richards S, Mai XM, Dong C. B7S1, a novel B7 family member that negatively regulates T cell activation. Immunity 2003;18:863–873. http://dx.doi.org/10.1016/S1074-7613(03)00147-X
- Sica GL, Choi IH, Zhu GF, et al. B7-H4, a molecule of the B7 family, negatively regulates T cell immunity. Immunity 2003;18:849–861. http://dx.doi.org/10.1016/S1074-7613(03)00152-3
- Zang X, Loke P, Kim J, et al. B7x: a widely expressed B7 family member that inhibits T cell activation. PNAS USA 2003;100:10388–10392. http://dx.doi.org/10.1073/pnas.1434299100
- Wang X, Hao J, Metzger DL, et al. Early treatment of NOD mice with B7-H4 reduces the incidence of autoimmune diabetes. Diabetes 2011;60:3246–3255. http://dx.doi.org/10.2337/db11-0375
- Mao YX, Chen YJ, Ge Y, et al. Recombinant human B7-H4 expressed in Escherichia coli inhibits T lymphocyte proliferation and IL-2 secretion in vitro. Acta Pharmacol Sin 2006;27:741–746. http://dx.doi.org/10.1111/j.1745-7254.2006.00338.x
- Podojil J, Miller S. B7-H4 Ig treatment during relapsing-remitting EAE increases the number and function of regulatory T cells. J Immunol 2012;188:123–137 (Meeting Abstract Supplement)
- Brimnes J, Reimann J, Nissen M, Claesson M. Enteric bacterial antigens activate CD4(+) T cells from SCID mice with inflammatory bowel disease. Eur J Immunol 2001;31:23–31. http://dx.doi.org/10.1002/1521-4141(200101)31:1<23::AID-IMMU23>3.0.CO;2-2
- Shevach EM, McHugh RS, Piccirillo CA, Thornton AM. Control of T-cell activation by CD4+ CD25+ suppressor T cells. Immunol Rev 2001;182:58–67. http://dx.doi.org/10.1034/j.1600-065X.2001.1820104.x
- Rasmussen SB, Claesson MH, Kristensen NN. In vitro activity and function of a B7-H4-fusion protein. Open J Immunol 2013;3:24–32. DOI: 10.4236/oji 2013.31004
- Fowler DH, Gress RE. Th2 and Tc2 cells in the regulation of GVHD, GVL, and graft rejection: considerations for the allogeneic transplantation therapy of leukemia and lymphoma. Leuk Lymphoma 2000;38:221–234. http://dx.doi.org/10.3109/10428190009087014
- Salomon B, Lenschow DJ, Rhee L, et al. B7/CD28 costimulation is essential for the homeostasis of the CD4+ CD25+ immunoregulatory T cells that control autoimmune diabetes. Immunity 2000;12:431–440. http://dx.doi.org/10.1016/S1074-7613(00)80195-8
- Serreze DV, Gaedeke JW, Leiter EH. Hematopoietic stem-cell defects underlying abnormal macrophage development and maturation in NOD/Lt mice: defective regulation of cytokine receptors and protein kinase C. Proc Natl Acad Sci USA 1993;90:9625–9629. http://dx.doi.org/10.1073/pnas.90.20.9625
- Kataoka S, Satoh J, Fujiya H, et al. Immunologic aspects of the nonobese diabetic (NOD) mouse. Abnormalities of cellular immunity. Diabetes 1983;32:247–253. http://dx.doi.org/10.2337/diabetes.32.3.247
- Naumov YN, Bahjat KS, Gausling R, et al. Activation of CD1d-restricted T cells protects NOD mice from developing diabetes by regulating dendritic cell subsets. Proc Natl Acad Sci USA 2001;98:13838–13843. http://dx.doi.org/10.1073/pnas.251531798
- Bettini M, Vignali DA. T cell-driven initiation and propagation of autoimmunediabetes. Curr Opin Immunol 2011;23:754–760. http://dx.doi.org/10.1016/j.coi.2011.10.002
- Kuerten S, Lehmann PV. The immune pathogenesis of experimental autoimmune encephalomyelitis: lessons learned for multiple sclerosis? J Interferon Cytokine Res. 2011;31:907–916. http://dx.doi.org/10.1089/jir.2011.0072
- Gad M, Kristensen NN, Kury E, Claesson MH. Characterization of T-regulatory cells, induced by immature dendritic cells, which inhibit enteroantigen-reactive colitis-inducing T-cell responses in vitro and in vivo. Immunology 2004;113:499–508. http://dx.doi.org/10.1111/j.1365-2567.2004.01977.x
- Petersen ER, Claesson MH, Schmidt EG, et al. Consumption of probiotics increases the effect of regulatory T cells in transfer colitis. Inflamm Bowel Dis 2012;18:131–142. http://dx.doi.org/10.1002/ibd.21709